-
公开(公告)号：US12121698B2
公开(公告)日：2024-10-22
申请号：US17511770
申请日：2021-10-27
Inventor： Michael A. Vogelbaum
CPC classification number: A61M5/14276 , A61M5/16804 , A61M2205/3334
Abstract: A medical device and method to deliver a liquid solution to a patient's tissue. In particular a medical device that is an infusion device comprising a plurality of delivery tubes with varying lengths and internal diameters so that when the selected plurality of delivery tubes are implanted there is equal impedance to flow through each of the attached delivery tubes resulting in equal flow out of the delivery tubes to regions of interest in the patient's tissue. The plurality of delivery tubes may be attached to an infusion hub in a regular symmetrical pattern or an irregular asymmetrical pattern as required to deliver liquid solution to a plurality of regions of interest in the patient's tissue.
-
公开(公告)号：US12121334B2
公开(公告)日：2024-10-22
申请号：US18449497
申请日：2023-08-14
Applicant: Respiratory Motion, Inc.
Inventor： Jenny E. Freeman , Jordan Brayanov , Malcolm G. Bock , Alexander Panasyuk
IPC: A61B5/0205 , A61B5/00 , A61B5/053 , A61B5/08 , A61B5/087 , A61B5/091 , A61B5/145 , A61M5/142 , A61M5/168 , A61M11/00 , A61M16/00 , G16H40/63 , G16H50/20 , G16H50/30 , A61M16/04
CPC classification number: A61B5/0205 , A61B5/0024 , A61B5/053 , A61B5/0803 , A61B5/0809 , A61B5/0816 , A61B5/087 , A61B5/091 , A61B5/14542 , A61B5/4848 , A61B5/6823 , A61B5/7278 , A61B5/746 , A61M5/14276 , A61M5/168 , A61M11/00 , A61M16/0006 , A61M16/0051 , A61M16/026 , G16H40/63 , G16H50/20 , G16H50/30 , A61B5/0022 , A61B2560/0228 , A61B2560/0431 , A61M2016/0036 , A61M16/0463 , A61M2205/18 , A61M2205/3375 , A61M2205/3569 , A61M2205/3592 , A61M2205/50 , A61M2230/06 , A61M2230/08 , A61M2230/10 , A61M2230/205 , A61M2230/30 , A61M2230/65 , A61M2230/65 , A61M2230/005
Abstract: Disclosed is a bioimpedance measurement system: A stabilized high frequency current generator is connected to PadSet electrodes via a Patient Cable. Electrodes are connected to an adaptive circuit that conditions the resulting voltage signal and converts it to digital form. Firmware performs signal acquisition and relays data to the device.
-
公开(公告)号：US20240342367A1
公开(公告)日：2024-10-17
申请号：US18752428
申请日：2024-06-24
Applicant: Medtronic, Inc.
Inventor： Erik J. Peterson , Touby A. Drew , Jerel K. Mueller , Sarah J. Offutt , Carl M. Feller
CPC classification number: A61M5/14276 , A61M5/1684 , G01F17/00 , A61M2205/18 , A61M2205/3375 , A61M2205/3379 , A61M2205/3389 , A61M2205/3584 , A61M2205/52
Abstract: A medical device includes a drug reservoir located within a reservoir chamber of the device that includes a first side and a second side directly opposite the first side defining a reservoir volume there between. The device further includes a volume sensor system including a transmitter positioned to transmit a signal toward the second side and one or more sensors configured to receive the signal and indicate a current volume capacity of the drug reservoir.
-
公开(公告)号：US20240315616A1
公开(公告)日：2024-09-26
申请号：US18734167
申请日：2024-06-05
Applicant: EFFERENT LABS, INC.
Inventor： William K. Rader , Spencer Z. Rosero
IPC: A61B5/1459 , A61B5/00 , A61B5/01 , A61B5/145 , A61M5/142
CPC classification number: A61B5/1459 , A61B5/0008 , A61B5/01 , A61B5/14514 , A61B5/14546 , A61B5/6832 , A61B2560/0443 , A61M5/14248 , A61M5/14276 , A61M2205/505
Abstract: A wearable device for monitoring physiological changes in a patient is provided. The device can include a housing adapted to being secured to a patient's body, the housing comprising a needle configured for fluid contact with a bodily fluid under a skin surface; a chamber having a cell layer and configured to monitor physiological changes in the bodily fluid and to generate one or more signals associated with the physiological changes; and a reader for detecting and/or decoding signals from the cell layer to monitor physiological changes in the patient. The device is capable of engaging in a two-way communication with a second device through transmission of one or more signals.
-
公开(公告)号：US20240299649A1
公开(公告)日：2024-09-12
申请号：US18599594
申请日：2024-03-08
Applicant: CraniUS LLC
Inventor： Owen FRIESEN , John CAI , Nathan SCOTT , Charles WATKINS , Anthony GARCIA , Conner DELAHANTY , Farooq AKHTAR , Rahul GANGWANI , Eleni DASKOPOULOU
IPC: A61M5/142
CPC classification number: A61M5/14276 , A61M2005/14208 , A61M2205/0227 , A61M2205/0233 , A61M2205/04 , A61M2205/106 , A61M2205/3313 , A61M2205/3327 , A61M2205/3334 , A61M2205/50 , A61M2205/8206
Abstract: According to at least one exemplary embodiment, an implanted medical pump sensing and control system may be provided. The pump sensing and control system may include a pump management circuit board. The pump sensing and control system may further include an implanted mainboard within a device, which may be a multilayer PCB that houses the control, communication, and power systems for the entire implanted device. The implanted mainboard may include one or more of a processor, a voltage control circuit, and/or a pump control circuit. The implanted mainboard may further communicate with the pump management board, and thereby control either a unidirectional or bidirectional pump.
-
Patent Agency Ranking
公开(公告)号：US20240293611A1
公开(公告)日：2024-09-05
申请号：US18573881
申请日：2022-07-07
Applicant: SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO SANT'ANNA , LIFECARE LABORATORY GMBH
Inventor： Hind AL-HADDAD , Izadyar TAMADON , Daniele GUARNERA , Arianna MENCIASSI , Paolo DARIO , Andreas PFÜTZNER , Fabio VISTOLI , Veronica IACOVACCI , Leonardo RICOTTI
CPC classification number: A61M5/14276 , A61M5/1723 , A61M2205/3515 , A61M2209/086 , A61M2210/1017
Abstract: The present invention generally relates to the controlled administration of substances through infusion devices implanted in the human body and more particularly has as an object an improved system for the controlled administration of a substance such as a drug, a hormone or a hormone complex and the like for which other administration modes result unsatisfactory or ineffective. More specifically, the invention is directed to such a system having an implanted infusion device provided with an improved docking group for reliably docking an ingestible substance carrier. The invention also relates to a special construction of the carrier.
-
公开(公告)号：US12073941B2
公开(公告)日：2024-08-27
申请号：US17984524
申请日：2022-11-10
Applicant: Abbott Diabetes Care Inc.
Inventor： Christopher V. Reggiardo , Namvar Kiaie , James Thomson
IPC: G06F21/30 , A61M5/142 , A61M5/172 , G06F21/44 , G16H20/17 , G16H40/63 , G16H40/67 , G16Z99/00 , H04L9/40 , H04W12/08 , A61B5/145 , A61M5/315
CPC classification number: G16H40/63 , A61M5/14244 , A61M5/14276 , A61M5/1723 , G06F21/30 , G06F21/44 , G16H20/17 , G16H40/67 , G16Z99/00 , H04L63/104 , H04L63/105 , H04W12/08 , A61B5/14532 , A61M5/31525 , A61M5/31546 , A61M2205/276 , A61M2205/3561 , A61M2205/3569
Abstract: Medical devices, systems, and methods related thereto a glucose monitoring system having a first display unit in data communication with a skin-mounted assembly, the skin-mounted assembly including an in vivo sensor and a transmitter. The first display unit and a second display unit are in data communication with a data management system. The first display unit comprises memory that grants a first user first access level rights and the second display unit comprises memory that grants a second individual second access level rights.
-
公开(公告)号：US20240282442A1
公开(公告)日：2024-08-22
申请号：US18653518
申请日：2024-05-02
Applicant: Abbott Diabetes Care Inc.
Inventor： Christopher V. REGGIARDO , Namvar KIAIE , James THOMSON
IPC: G16H40/63 , A61B5/145 , A61M5/142 , A61M5/172 , A61M5/315 , G06F21/30 , G06F21/44 , G16H20/17 , G16H40/67 , G16Z99/00 , H04L9/40 , H04W12/08
CPC classification number: G16H40/63 , A61M5/14244 , A61M5/14276 , A61M5/1723 , G06F21/30 , G06F21/44 , G16H20/17 , G16H40/67 , G16Z99/00 , H04L63/104 , H04L63/105 , H04W12/08 , A61B5/14532 , A61M5/31525 , A61M5/31546 , A61M2205/276 , A61M2205/3561 , A61M2205/3569
Abstract: Medical devices, systems, and methods related thereto a glucose monitoring system having a first display unit in data communication with a skin-mounted assembly, the skin-mounted assembly including an in vivo sensor and a transmitter. The first display unit and a second display unit are in data communication with a data management system. The first display unit comprises memory that grants a first user first access level rights and the second display unit comprises memory that grants a second individual second access level rights.
-
公开(公告)号：US12029559B2
公开(公告)日：2024-07-09
申请号：US16991456
申请日：2020-08-12
Applicant: EFFERENT LABS, INC.
Inventor： William K. Rader , Spencer Z. Rosero
IPC: A61B5/145 , A61B5/00 , A61B5/01 , A61B5/1459 , A61M5/142
CPC classification number: A61B5/1459 , A61B5/0008 , A61B5/01 , A61B5/14514 , A61B5/14546 , A61B5/6832 , A61B2560/0443 , A61M5/14248 , A61M5/14276 , A61M2205/505
Abstract: A wearable device for monitoring physiological changes in a patient is provided. The device can include a housing adapted to being secured to a patient's body, the housing comprising a needle configured for fluid contact with a bodily fluid under a skin surface; a chamber having a cell layer and configured to monitor physiological changes in the bodily fluid and to generate one or more signals associated with the physiological changes; and a reader for detecting and/or decoding signals from the cell layer to monitor physiological changes in the patient. The device is capable of engaging in a two-way communication with a second device through transmission of one or more signals.
-
公开(公告)号：US20240139479A1
公开(公告)日：2024-05-02
申请号：US18499078
申请日：2023-10-31
Applicant: Rani Therapeutics, LLC
Inventor： Mir Imran
CPC classification number: A61M31/002 , A61M5/14276 , A61M25/0116 , A61M25/10 , A61M31/00 , A61M31/007 , A61M2205/3331 , A61M2205/3344 , A61M2205/3368 , A61M2205/8231 , A61M2210/1042 , A61M2210/1053 , A61M2230/208 , A61M2230/60
Abstract: Embodiments of the invention provide swallowable devices, preparations, and methods for delivering drugs and other therapeutic agents within the GI tract. Particular embodiments provide a swallowable device such as a capsule for delivering drugs or other therapeutic agents (TA) into a wall of the GI tract such as the stomach or small intestine. The swallowable device comprises a sensor, a combustible propellant (CP) and a therapeutic agent preparation (TAP) comprising at least one TA. The sensor triggers the CP to ignite and propel the TAP into the wall of the GI tract in response to an external condition or change in external condition. Embodiments of the invention are particularly useful for orally delivering drugs or other TAs which are degraded within the GI tract and require parenteral injection.
-
-
-
-
-
-
-
-
-
Search Results
3505
records
(took 0.023 seconds)
